KR960016729A - 영양보강 우유 - Google Patents

영양보강 우유 Download PDF

Info

Publication number
KR960016729A
KR960016729A KR1019950041340A KR19950041340A KR960016729A KR 960016729 A KR960016729 A KR 960016729A KR 1019950041340 A KR1019950041340 A KR 1019950041340A KR 19950041340 A KR19950041340 A KR 19950041340A KR 960016729 A KR960016729 A KR 960016729A
Authority
KR
South Korea
Prior art keywords
milk
dairy product
acid
dairy
diseases
Prior art date
Application number
KR1019950041340A
Other languages
English (en)
Inventor
프레데릭 호로빈 데이비드
Original Assignee
스코티아 홀딩스 피엘씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9422897A external-priority patent/GB9422897D0/en
Priority claimed from GBGB9425101.4A external-priority patent/GB9425101D0/en
Application filed by 스코티아 홀딩스 피엘씨. filed Critical 스코티아 홀딩스 피엘씨.
Publication of KR960016729A publication Critical patent/KR960016729A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은, GLA 및/또는 DGLA를 보강한 우유 또는 유제품에 관한 것으로, GLA 및/또는 DGLA를 100㎎∼30g/100㎖, 바람직하게는 150㎎∼5g/100㎖, 보다 바람직하게는 200㎎∼2g/100㎖의 양으로 함유하고, 임의적으로 AA, SA, EPA 또는 DHA 등의 지방산을 1㎎∼30g/l00㎖의 양으로 더 함유한다.

Description

영양보강 우유
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 n-6 또는 n-3 계열의 필수지방산의 전환경로를 보여주는 도면이다.

Claims (15)

  1. 감마-리놀렌산(gamma-linolenic acid; GLA) 및/또는 디호모감마리놀렌산(dihomogammalinolenic acid; DGLA)를, 우유 100㎖당 또는 유제품 50㎖당 100mg∼30g, 바람직하게는 150mg∼5g, 보다 바람직하게는 200mg∼2g의 양으로 함유하고 ; 우유 또는 유제품 100㎖당, 아라키돈산(arachidonic acid; AA), 스테아리돈산(stearidonic acid; SA), 에이코사펜타에노산(eicosapentaenoic acid; EPA) 또는 도코사헥사에노산(docosahexaenoic acid; DHA) 중에서 선택된 1종 이상의 지방산을 1mg∼30g의 양으로 더 함유함을 특징으로 하는 GLA 및/또는 DGLA를 보강한 우유 또는 유제품.
  2. 제1항에 있어서, 칼슘을 적절한 융합 형태로, 칼슘함량이 100㎖ 당 50mg∼2000mg의 양이 되도록 더 함유하고, 임의적으로 그 밖의 지방산, 특히 EPA를 더 함유함을 특징으로 하는 우유 또는 유제품.
  3. 제1항 또는 제2항에 있어서, 칼슘 흡수와 칼슘 균형의 강화 및 골다공증의 치료 및/또는 예방을 목적으로 함을 특징으로 하는 우유 또는 유제품.
  4. 제1항에 있어서, 습진 및 좌창 등의 피부병 ; 당뇨병 및 이의 합병증 ; 고형압중과 관상혈관계(coronary) 및 말초혈관계 질환을 포함하는 그 밖의 심장혈관계 질환 ; 유(類)류머티스 및 골관절염, 전신계의 낭창홍반, 크론병, 궤양성대장염 및 그 밖의 질환 등의 염증질환 ; 천식 등의 호흡기 질환 ; 정신분열증 및 알코올중독 등의 정신병 ; 소화성 궤양 등의 위장병 ; 여러가지 암 ; 골다공증 ; 전립선 질환 ; 및 신장기능손상을 포함하는 질병들의 예방 및/또는 치료를 목적으로 함을 특징으로 하는 우유 또는 유제품.
  5. 제1항에 있어서, 과민성 습진(atopic eczema)의 예방 및/또는 치료를 목적으로 함을 특징으로 하는 우유 또는 유제품.
  6. 제1항에 있어서, 유(類)류머티스 및 골관절염의 예방 및/또는 치료를 목적으로, 임의적으로 EPA 또는 DHA를 더 함유함을 특징으로 하는 우유 또는 유제품.
  7. 제1항에 있어서, 정신분열증 또는 알코올중독의 치료를 목적으로, 임의적으로 EPA, DHA 또는 AA를 더 함유함을 특징으로 하는 우유 또는 유제품.
  8. 1항에 있어서, 고혈압증, 관동맥질환 또는 말초혈관계질환의 치료를 목적으로, 임의적으로 EPA, DHA 또는 AA를 더 함유함을 특징으로 하는 우유 또는 유제품.
  9. 제1항에 있어서, 천식 및 당뇨병과 이의 합병증의 예방 및/또는 치료를 목적으로, 임의적으로 그 밖의 지방산이나 아스코르브산 또는 아스코르브산염 등의 영양소를 1Omg∼20O0mg/100㎖의 양으로 더 함유함을 특징으로 하는 우유 또는 유제품.
  10. 제1항에 있어서, 전립선 비대를 포함한 전립선 질환의 예방 및/또는 치료를 목적으로, 임의적으로 그 밖의 지방산 및 아연 등의 그 밖의 영양소를 1mg∼800mg/1O0㎖의 양으로 더 함유함을 특징으로 하는 우유 또는 유제품.
  11. 제1항에 있어서, 암환자의 체력유지를 위한 영양보충을 목적으로, 임의적으로 그 밖의 지방산이나 아스코르브산 또는 아스코르브산염 등의 그 밖의 영양소를 10mg∼2000mg/100㎖의 양으로 함유함을 특징으로 하는 우유 또는 유제품.
  12. 제1항 내지 제11항 중 어느 한 항에 있어서, 인지질 또는 합성유화제, 바람직하게는 식물 갈라토리피드 또는 우유 스핀고리피드 등의 적절한 유화제를 더 함유함을 특징으로 하는 우유 또는 유제품.
  13. 제1항 내지 제12항 중 어느 한 항에 있어서, 젓소, 염소, 양 또는 낙타 등의 우유 또는 유제품에 상기한 지방산이나 그 밖의 영양소를 더 함유함을 특징으로 하는 우유 또는 유제품.
  14. 제1항 내지 제12항 중 어느 한 항에 있어서, 우유는 인공우유 또는 그 밖의 우유대용품의 형태이며, 유제품은 이들로부터 유도된 것임을 특징으로 하는 우유 또는 유제품.
  15. 제1항 내지 제14항 중 어느 한 항에 있어서, 우유는 요거트, 크림, 생치즈(fromage frais), 치즈, 버터 및 그 밖의 유제품의 형태이며, 유제품은 이들로부터 선택된 것임을 특징으로 하는 우유 또는 유제품.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950041340A 1994-11-14 1995-11-14 영양보강 우유 KR960016729A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9422897A GB9422897D0 (en) 1994-11-14 1994-11-14 Fortified cows milk
GB9422897.0 1994-11-14
GB9425101.4 1994-12-13
GBGB9425101.4A GB9425101D0 (en) 1994-12-13 1994-12-13 Fortified milk

Publications (1)

Publication Number Publication Date
KR960016729A true KR960016729A (ko) 1996-06-17

Family

ID=26305976

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950041340A KR960016729A (ko) 1994-11-14 1995-11-14 영양보강 우유

Country Status (9)

Country Link
EP (1) EP0711503A3 (ko)
JP (1) JPH08205769A (ko)
KR (1) KR960016729A (ko)
CN (1) CN1135841A (ko)
AU (1) AU3782895A (ko)
CA (1) CA2162739A1 (ko)
FI (1) FI955449A (ko)
NO (1) NO954573L (ko)
NZ (1) NZ280457A (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100651175B1 (ko) * 2004-10-20 2006-12-01 학교법인 건국대학교 칼슘강화 정제형 제품 및 그의 제조방법

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9510636D0 (en) * 1995-05-25 1995-07-19 Scotia Holdings Plc Fatty acid treatment
US6340485B1 (en) 1996-06-03 2002-01-22 Croda International Plc Compositions and uses thereof
AU2972497A (en) * 1996-06-03 1998-01-05 Croda International Plc Treatment of oils
US6331567B1 (en) 1997-06-13 2001-12-18 Mars Uk Limited Edible composition containing zinc and linoleic acid
GB9712420D0 (en) * 1997-06-13 1997-08-13 Mars Uk Ltd Food
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EA200100662A1 (ru) * 1998-12-15 2001-12-24 Американ Хоум Продактс Корпорейшн Способ и композиция для поддержания и восстановления целостности кишки
NO313076B1 (no) 1999-12-28 2002-08-12 Pronova Biocare As Flytende n¶rings- og/eller nytelsesmiddel og fremgangsmåte for fremstilling derav
GB0016045D0 (en) 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
JP4738714B2 (ja) * 2000-11-13 2011-08-03 日本水産株式会社 Ｅｐａ高濃度含有豆乳類及びその製造方法
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7988989B2 (en) * 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
GB2422373B (en) 2003-08-18 2008-05-21 Btg Int Ltd Treatment of neurodegenerative conditions
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
CA2599112C (en) * 2005-02-14 2013-10-22 Suntory Limited Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
EP1714564A1 (en) * 2005-04-21 2006-10-25 N.V. Nutricia Method for treatment and prevention of respiratory insufficiency
ES2366034T3 (es) * 2005-12-23 2011-10-14 N.V. Nutricia Composición que comprende ácidos grasos poliinsaturados, proteínas, manganeso y/o molibdeno y nucleósidos/nucleótidos para el tratamiento de la demencia.
CN100391353C (zh) * 2006-01-06 2008-06-04 石家庄三鹿集团股份有限公司 新生婴儿配方奶粉
US8871808B2 (en) 2006-06-22 2014-10-28 Ben-Gurion University Of The Negev Research And Development Authority Et Al. Over-production of dihomo linolenic acid by a mutant strain of Parietochloris incisa
JP4816730B2 (ja) 2006-10-31 2011-11-16 不二製油株式会社 高度不飽和脂肪酸含有飲食品及びその製造法
EP1961311A1 (en) * 2007-02-23 2008-08-27 Belovo S.A., Egg Science & Technology Food comprising polyunsaturated fatty acids for the prevention of chronic diseases
AU2007357796B2 (en) * 2007-08-13 2014-05-08 Ben-Gurion University Of The Negev Research And Development Authority Over-production of dihomo gamma linolenic acid by a mutant strain of Parietochloris incisa
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CN102318859A (zh) * 2011-07-20 2012-01-18 孔凡艮 花生芽榨汁饮品生产工艺
SG11201809177UA (en) * 2016-06-01 2018-12-28 Nestec Sa Composition for use in the prophylaxis of allergic disease
US10639313B2 (en) 2017-09-01 2020-05-05 Ndsu Research Foundation Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1446431A (en) * 1972-04-20 1976-08-18 Williams J Nutritional supplement
US5324748A (en) * 1981-07-14 1994-06-28 Efamol Limited Method for enhancement of 1-series PG production
FR2522935A1 (fr) * 1982-03-10 1983-09-16 Chevalier Jacques Nouveaux produits a base de lait et de ses derives riches en acides gras polyinsatures et leur procede de preparation
ATE24266T1 (de) * 1982-04-16 1987-01-15 Nestle Sa Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
US4670285A (en) 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
FR2553261B1 (fr) 1983-10-14 1986-02-21 Bio Extraction Lait artificiel pour l'alimentation des nouveaux-nes et des jeunes enfants
EP0175468A3 (en) * 1984-08-10 1987-07-22 Sentrachem Limited Eicosanoids for use in cancer therapy
JPS6187621A (ja) * 1984-10-05 1986-05-06 Nisshin Oil Mills Ltd:The アレルギ−性鼻炎及びアレルギ−性喘息治療薬
JPS61224932A (ja) * 1985-03-30 1986-10-06 Agency Of Ind Science & Technol ガンマリノレン酸成分添加ミルク
JPS6279732A (ja) * 1985-10-02 1987-04-13 Agency Of Ind Science & Technol ガンマリノレン酸含有トリグリセリド添加ミルク
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
CH676909A5 (ko) * 1988-12-23 1991-03-28 Nestle Sa
DE69025787T2 (de) * 1989-04-04 1996-10-31 Beiersdorf Ag Mittel zur Atopieprophylaxe
DE3920679A1 (de) * 1989-06-23 1991-01-10 Milupa Ag Fettmischung zur herstellung von nahrungen, insbesondere saeuglingsnahrungen
GB8916734D0 (en) * 1989-07-21 1989-09-06 Efamol Holdings Pharmaceutical and dietary uses of fatty acids
FR2653972B1 (fr) * 1989-11-07 1993-07-09 Perrier Sante Sa Phase grasse pour produits alimentaires et matieres alimentaires comparables a la creme contenant ladite phase grasse et leur procede de preparation.
GB9026648D0 (en) * 1990-12-07 1991-01-23 Efamol Holdings Nutrition
GB2254556B (en) * 1991-04-11 1995-04-12 Fisons Plc Formulations containing linolenic acid
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment
GB9213322D0 (en) 1992-06-23 1992-08-05 Efamol Holdings Antioxidant compositions
GB9217780D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100651175B1 (ko) * 2004-10-20 2006-12-01 학교법인 건국대학교 칼슘강화 정제형 제품 및 그의 제조방법

Also Published As

Publication number Publication date
AU3782895A (en) 1996-05-23
JPH08205769A (ja) 1996-08-13
NO954573L (no) 1996-05-15
EP0711503A3 (en) 1997-11-26
NO954573D0 (no) 1995-11-13
CA2162739A1 (en) 1996-05-15
FI955449A (fi) 1996-05-15
FI955449A0 (fi) 1995-11-13
NZ280457A (en) 1997-11-24
EP0711503A2 (en) 1996-05-15
CN1135841A (zh) 1996-11-20

Similar Documents

Publication Publication Date Title
KR960016729A (ko) 영양보강 우유
KR960016781A (ko) 영양이 보강된 과일 쥬스
Goyal et al. Fortification of dahi (Indian yoghurt) with omega-3 fatty acids using microencapsulated flaxseed oil microcapsules
Herzallah et al. Effect of heating and processing methods of milk and dairy products on conjugated linoleic acid and trans fatty acid isomer content
Estrada et al. Developing a strawberry yogurt fortified with marine fish oil
CA2129452A1 (en) Nutritional product for pulmonary patients
CN100527966C (zh) 在动物奶中添加多不饱和脂肪酸的方法
US8461363B2 (en) Deodorization and stabilization of marine oils
CA2825338C (en) Nutritional products comprising beta-hydroxy-beta-methylbutyrate
KR101586502B1 (ko) 마린 오일의 탈취 및 안정화
JP2008538916A (ja) 脂質封入
EP2709460A1 (en) Composition comprising vitamin k2
TWI265785B (en) EPA and/or DHA-containing acidic milks
WO2009032728A2 (en) Preparation of fatty acids in solid form
AU2001250731A1 (en) Lipid composition and use thereof
DK0754001T3 (da) Næringsmiddelprodukt til behandling af colitis ulcerosa og anvendelse deraf
RU2011147131A (ru) Молочный продукт, стимулирующий чувство сытости
Poonia Emerging opportunities for effective valorization of dairy by-products
Rodríguez-Pérez et al. New trends and perspectives in functional dairy-based beverages
Tallapragada et al. Recent trends and developments in milk-based beverages
Shahidi et al. Beverages fortified with omega-3 fatty acids, dietary fiber, minerals, and vitamins
US20160310596A1 (en) Composition comprising ferric saccharate and high concentrations of microencapsulated lc-pufa with a reduced off taste
Romero et al. Concentration of conjugated linoleic acid from milk fat with a continuous supercritical fluid processing system
Jang et al. Preparation and quality characteristics of different mackerel Scomber japonicas-based processed products as senior-friendly seafoods
McBean et al. Nutritive value of dairy foods

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid